A phase ii study of glembatumumab vedotin for metastatic uveal melanoma

Merve Hasanov, Matthew J. Rioth, Kari Kendra, Leonel Hernandez-Aya, Richard W. Joseph, Stephen Williamson, Sunandana Chandra, Keisuke Shirai, Christopher D. Turner, Karl Lewis, Elizabeth Crowley, Jeffrey Moscow, Brett Carter, Sapna Patel

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'A phase ii study of glembatumumab vedotin for metastatic uveal melanoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science